Golden Sun Health Technology Group (GSUN) appoints Duo Ye as COO role

Rhea-AI Filing Summary

Golden Sun Health Technology Group Limited reported a change in its chief operating officer role. On September 18, 2025, Ms. Xiaoyi Wang resigned as COO for personal reasons, and the company stated her departure did not involve any dispute with management or the board. The board appointed Mr. Duo Ye as the new COO, effective the same day.

Mr. Ye brings more than a decade of senior management experience across financial services, asset management, cultural media, and cross-border e-commerce. On September 24, 2025, the company entered into a three-year employment agreement with him, running from September 18, 2025 to September 17, 2028, with automatic renewal unless either party gives two months’ notice. He will receive a monthly salary of $3,233 plus standard benefits, and the agreement allows termination for cause and includes customary confidentiality and non-disclosure covenants. The company states there are no family relationships or related-party transactions involving Mr. Ye.

Insights

Corporate governance analyst

COO transition appears orderly with a standard three-year employment pact.

The company reports an executive transition where former COO Xiaoyi Wang resigned for personal reasons, explicitly noting no disagreements with management or the board. The board filled the role immediately by appointing Duo Ye effective the same date, which limits any operational gap in day-to-day leadership.

Mr. Ye’s background spans asset management, trust services, cultural media, and cross-border e-commerce, which may align with the company’s broader strategic focus as described. His employment agreement provides a monthly salary of $3,233 and standard benefits over a three-year term ending on September 17, 2028, with automatic renewal and customary confidentiality and for-cause termination provisions. Overall, this looks like a routine leadership change with standard contractual terms.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of September 2025

Commission File Number: 001-41425

金太阳健康科技集团有限公司

(Translation of registrant’s name into English)

Golden Sun Health Technology Group Limited

Room 503, Building C2, No. 1599

Xinjinqiao Road, Pudong New Area

Shanghai, China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Resignation and Appointment of Chief Operating Officer

On September 18, 2025, Ms. Xiaoyi Wang resigned as the Chief Operating Officer (“COO”) of Golden Sun Health Technology Group Limited (the “Company”), effective on September 18, 2025. Ms. Wang’s resignation was due to personal reasons and was not the result of any disputes or disagreement with the Company or its board of directors on any matter relating to the Company’s operations, policies or practices.

On September 23, 2025, the board of directors of the Company appointed Mr. Duo Ye as COO of the Company, effective on September 18, 2025, to fill in the vacancy.

Mr. Duo Ye has extensive experience in the financial services and media industries, with over a decade in senior management roles. From November 2023 to September 2025, he was the General Manager at Zhejiang Jintaiyang Selection Technology Co., Ltd., a company focused on cross border e-commerce, cultural and tourism planning services, and information technology services. From December 2020 to October 2023, he served as Chief Operating Officer of Jinhua Single Dog Culture Media Co., Ltd., a company primarily engaged in cultural tourism planning services, information technology services, and online live streaming expert training. Between October 2014 to October 2020, he served as General Manager of Shanghai Nuoxin Asset Management Co., Ltd., a company focused on asset management and industrial investment, and between December 2010 to October 2014, he served as Deputy General Manager of the Institutional Business Department at Xinhua Trust Co., Ltd., a company primarily engaged in trust and fund business. Earlier in his career, he served as a Branch Manager at the Daikoku Hotel Group in New Zealand, a company focused on accommodation and catering services. Mr. Ye received an MBA from the City University of Macau in Macau in 2016 and a diploma in hospitality from Auckland Wise Institute in Auckland in 2006.

On September 24, 2025, the Company entered into an employment agreement with Mr. Ye, pursuant to which Mr. Ye is entitled to receive a monthly salary of $3,233, plus standard employee benefits granted by the Company. The term of this agreement is three years, commencing from September 18, 2025 to September 17, 2028, subject to automatic renewal unless a two-month advance notice by either party to terminate the agreement prior to the expiration of such term, or early termination by either party pursuant to the terms of the agreement. The Company may terminate the employment for cause, at any time, without notice or remuneration, for certain acts of the executive officer, including but not limited to the commitments of any serious or persistent breach or non-observance of the terms and conditions of the employment, conviction of a criminal offense, willful disobedience of a lawful and reasonable order, fraud or dishonesty, receipt of bribery, or severe neglect of his duties. The agreement also contains customary covenants related to confidentiality and non-disclosure.

There are no family relationships between Mr. Ye and any director or executive officer of the Company. There are no transactions between the Company and Mr. Ye that are subject to disclosure under Item 404(a) of Regulation S-K.

The foregoing description of the employment agreement with Mr. Ye is a summary only and does not purport to be complete, and is qualified in its entirety by reference to the full text of such document, the form of which is attached hereto as Exhibit 10.1, and incorporated herein by reference.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Golden Sun Health Technology Group Limited
	By:	/s/ Xueyuan Weng
		Name:	Xueyuan Weng
		Title:	Chief Executive Officer

Date: September 24, 2025

2

EXHIBIT INDEX

Exhibit Number		Description
10.1		Employment Agreement, dated September 24, 2025, between the Company and Duo Ye.

3

FAQ

What leadership change did GSUN disclose in this Form 6-K?

Golden Sun Health Technology Group Limited disclosed that former COO Ms. Xiaoyi Wang resigned on September 18, 2025, and that the board appointed Mr. Duo Ye as the new Chief Operating Officer effective the same date.

Why did GSUNs former COO Xiaoyi Wang resign?

The company states that Ms. Xiaoyi Wang resigned as COO on September 18, 2025, due to personal reasons and that her resignation was not the result of any disputes or disagreements with the company or its board regarding operations, policies, or practices.

What is the background of GSUNs new COO, Duo Ye?

Mr. Duo Ye has extensive senior management experience in financial services and media. His roles have included General Manager at Zhejiang Jintaiyang Selection Technology Co., Ltd., COO at Jinhua Single Dog Culture Media Co., Ltd., General Manager at Shanghai Nuoxin Asset Management Co., Ltd., and Deputy General Manager at Xinhua Trust Co., Ltd. He holds an MBA from the City University of Macau (2016) and a hospitality diploma from Auckland Wise Institute (2006).

What are the key terms of GSUNs employment agreement with COO Duo Ye?

The employment agreement, entered into on September 24, 2025, provides Mr. Duo Ye a monthly salary of $3,233 plus standard employee benefits. The term is three years, from September 18, 2025 to September 17, 2028, with automatic renewal unless either party gives two months prior notice or terminates earlier under the agreement.

Can GSUN terminate COO Duo Yes employment early under the agreement?

Yes. The company may terminate Mr. Yes employment for cause at any time without notice or remuneration for specified reasons, including serious or persistent breach of the agreement, conviction of a criminal offense, willful disobedience of lawful and reasonable orders, fraud or dishonesty, receipt of bribery, or severe neglect of duties.

Are there any related-party or family relationships involving GSUNs new COO?

The company states there are no family relationships between Mr. Duo Ye and any director or executive officer and that there are no transactions between the company and Mr. Ye requiring disclosure under Item 404(a) of Regulation S-K.